Clinical trial

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily

NCT00314626

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-11-01

PhasePHASE3

Study timeline

Study start (unknown)2004-11-01Date precision: month

Registry last updated2008-01-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

efavirenzDRUG · verified · RxNorm: efavirenz

Abacavir+lamivudineDRUG

Sponsors & collaborators

Germans Trias i Pujol Hospitallead sponsor

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Cienciacollaborator

Mapped research locations

MadridMadrid, Spain1 BarcelonaBarcelona, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00314626 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.